Nanotechnology might not be immediately evident in a small, isolated village in India, but Steve Walsh says such a place offers an important example of what drives nanobiomedical innovation.
Residents there don’t have access to major testing labs, nor do they have the financial means for expensive care. But they can now take advantage of the latest in AIDS testing technology. They just need to blot a drop of blood on a piece of paper. Biotechnology combines with microfluidics to make a chemical indicator that looks like nothing more than a postage stamp-sized piece of paper. The result is a diagnostic test that is both accurate and cheap — two criteria necessary for making testing for AIDS and other diseases globally accessible.
To read the full, original article click on this link: Emerging markets: A new driver for nanobiotechnology innovation
Author:Frank Vinluan
